Paying Parties
Cream Consulting campaign for PMCB
| Emails Sent: | 3 | ||
| Estimated volume generated: | $0 | ||
| Total Paid: | $15,000 | ||
**PMCB** Ready for a Fight! Jun 22, 2015
Trouble viewing this email? Read it online
Today's pick is: **PMCB**
Hello Traders,
Traders are always on the hunt for undiscovered biotech stocks that could be potential acquisition targets or are close to releasing positive results from trials. These stocks can see HUGE explosions on such news!
Our newest alert is PMCB
PMCB is a clinical stage biotechnology company that could revolutionize the way we treat cancer
...read more
| Promoter: | Penny Stock Circle |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| PMCB | $15,000 | UNKNOWN |
| Max Profit: 1.19 % | Gain at close: Pending |
**PMCB** Ready for a Fight! Jun 22, 2015
Trouble viewing this email? Read it online
Today's pick is: **PMCB**
Hello Traders,
Traders are always on the hunt for undiscovered biotech stocks that could be potential acquisition targets or are close to releasing positive results from trials. These stocks can see HUGE explosions on such news!
Our newest alert is PMCB
PMCB is a clinical stage biotechnology company that could revolutionize the way we treat cancer
...read more
| Promoter: | 1-2-3 Stock Alerts |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| PMCB | $15,000 | UNKNOWN |
| Max Profit: 1.19 % | Gain at close: Pending |
**PMCB** Ready for a Fight! Jun 22, 2015
Trouble viewing this email? Read it online
Today's pick is: **PMCB**
Hello Traders,
Traders are always on the hunt for undiscovered biotech stocks that could be potential acquisition targets or are close to releasing positive results from trials. These stocks can see HUGE explosions on such news!
Our newest alert is PMCB
PMCB is a clinical stage biotechnology company that could revolutionize the way we treat cancer
...read more
| Promoter: | StockMister |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| PMCB | $15,000 | UNKNOWN |
| Max Profit: 1.19 % | Gain at close: Pending |